menu
    • menu

    Company profile for Celularity

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Celularity is a clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer immunotherapy and functional regeneration. Some of our placenta-derived allogeneic cell therapy products aim to augment immunity by harnessing a patient’s own immune system to combat disease. Our other products seek to augment longevity by targeting organ a...
    Celularity is a clinical-stage cell therapeutics company delivering transformative allogeneic cellular therapies, engineered from the postpartum human placenta, in cancer immunotherapy and functional regeneration. Some of our placenta-derived allogeneic cell therapy products aim to augment immunity by harnessing a patient’s own immune system to combat disease. Our other products seek to augment longevity by targeting organ and tissue repair and functional regeneration. With this approach, our ambition is to augment human immunity and longevity, and to improve the human health span.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CelularityUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    33 Technology Drive Warren, NJ 07059
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://celularity.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Celularity CEO Comments on Centers for Medicare Services
    Celularity CEO Comments on Centers for Medicare Services

    26 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/26/3210532/0/en/Celularity-CEO-Comments-on-Centers-for-Medicare-Medicaid-Services-Withdrawal-of-Skin-Substitute-Local-Coverage-Determinations.html

    GLOBENEWSWIRE
    26 Dec 2025
    Share Share
    Celularity Secures Financing For Strategic Vision
    Celularity Secures Financing For Strategic Vision

    18 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/18/3208116/0/en/Celularity-Reaches-Binding-Term-Sheets-on-Financing-Transactions-to-Support-Its-Strategic-Vision.html

    GLOBENEWSWIRE
    18 Dec 2025
    Share Share
    Celularity Partners Defeye For Advancing Regenerative Eye Care
    Celularity Partners Defeye For Advancing Regenerative Eye Care

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177365/0/en/Celularity-and-DefEYE-Inc-Partner-to-Advance-Growth-of-Regenerative-Therapies-in-Eye-Care.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Celularity Publishes Ph2 Data on PDA-002 for Diabetic Foot Ulcers
    Celularity Publishes Ph2 Data on PDA-002 for Diabetic Foot Ulcers

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166225/0/en/Celularity-Announces-Peer-Reviewed-Publication-of-Phase-2-Clinical-Trial-Results-Demonstrating-the-Safety-and-Efficacy-of-Human-Placenta-Derived-Cells-PDA-002-for-Diabetic-Foot-Ulc.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Celularity Gets Nasdaq Notice Over Form 10-Q
    Celularity Gets Nasdaq Notice Over Form 10-Q

    22 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/22/3138055/0/en/Celularity-Receives-Nasdaq-Notice-Regarding-Form-10-Q.html

    GLOBENEWSWIRE
    22 Aug 2025
    Share Share
    Celularity Retires $41.6 M in Senior Secured Debt
    Celularity Retires $41.6 M in Senior Secured Debt

    18 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/18/3134978/0/en/Celularity-Completes-Major-Balance-Sheet-Restructuring-Retires-All-41-6-Million-in-Senior-Secured-Debt.html

    GLOBENEWSWIRE
    18 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search